Active Topics
Memberlist
Search
Help
Register
Login
Post Reply
Full Tilt Forum
:
General Discussion
: Post Reply
*Indicates required fields
Name*:
-- Font --
Arial
Courier New
Times New Roman
Verdana
-- Size --
1
2
3
4
5
6
-- Colour --
Black
White
Blue
Red
Green
Yellow
Orange
Brown
Magenta
Cyan
Lime Green
Mode:
Prompt
Basic
Message*:
Emoticons
more...
[QUOTE=business loan calcul] In May the US Food and Drug Administration found thatalong with other PDE inhibitors was associated with vision impairment related to NAION nonarteritic anterior ischemic optic neuropathy in certain patients taking these drugs in the postmarketing outside of clinical trials setting Most butall of these patients had underlying anatomic or vascular risk factors for development of NAION unrelated to PDE use including low cup to disc ratio “crowded disc” age over diabetes hypertension coronary artery disease hyperlipidemia and smoking Given the small number of NAION events with PDE use less thaninmillion the large number of users of PDE inhibitors millions and the fact that this event occurs in a similar population to those who dotake these medicines the FDA concluded that they wereable to draw a cause and effect relationship given these patients underlying vascular risk factors or anatomical defects However the label of all three PDE inhibitors was changed to alert clinicians to a possible association, [URL= http://www.sjzgcc.org/lenders.php?bad-credit-instant-approval]bad credit auto financing[/URL], :-]]], [/QUOTE]
Enable
Forum Codes
to format post
Powered by
Web Wiz Forums
version 7.7a
Copyright ©2001-2004
Web Wiz Guide
This page was generated in 0.3555 seconds.